If you’re borrowing regardless of your ability to repay, you may end up paying back much more than you initially borrowed.
Right now, that's none other than Eli Lilly (NYSE: LLY). However, others are looking to challenge its dominance. Recent comments from Pfizer 's (NYSE: PFE) CEO, Albert Bourla, suggest it could become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback